CUMBERLAND PHARMACEUTICALS INC Business Finance Contracts & Agreements

First Amendment to Amended and Restated Revolving Credit Loan Agreement, dated March 31, 2024, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on May 10, 2024)

Description of Cumberland Pharmaceutical's Common Stock (Filed With SEC on March 13, 2024)

Revolving Credit Loan Agreement, dated as of September 5, 2023, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on September 6, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between John M. Hamm and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 12, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Chris Bitterman and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 12, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Todd Anthony and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 12, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Jim Herman and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 12, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 12, 2023)

Description of Cumberland Pharmaceutical's Common Stock (Filed With SEC on March 13, 2023)

Ninth Amendment to Revolving Credit Loan Agreement, dated as of September 29, 2022, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on November 14, 2022)

Eighth Amendment to Revolving Credit Loan Agreement, dated as of June 30, 2022, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on August 12, 2022)

Seventh Amendment to Revolving Credit Loan Agreement, dated as of March 31, 2022, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on May 13, 2022)

Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between James L. Herman and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 13, 2022)

Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between John M. Hamm and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 13, 2022)

Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between Leo B. Pavliv and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 13, 2022)

Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 13, 2022)

Fifth Amendment to the Revolving Credit Note and Sixth Amendment to Revolving Credit Loan Agreement, dated as of December 31, 2021, by and between Cumberland Pharmaceuticals Inc.... (Filed With SEC on March 11, 2022)

Description of Cumberland Pharmaceutical's Common Stock (Filed With SEC on March 11, 2022)

Asset Purchase Agreement, dated December 31, 2021, by and among Cumberland Pharmaceuticals Inc. and Kyowa Kirin, Inc (Filed With SEC on January 6, 2022)

Fourth Amendment to Revolving Credit Note and Fifth Amendment to Revolving Credit Loan Agreement, dated as of October 28, 2021, by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on November 12, 2021)

Description of Cumberland Pharmaceutical's Common Stock (Filed With SEC on March 12, 2021)

Third Amendment to Revolving Credit Note and Fourth Amendment to Revolving Credit Loan Agreement, dated as of October 7, 2020 by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on November 13, 2020)

Second Amendment to Revolving Credit Note and Third Amendment to Revolving Credit Loan Agreement, dated as of May 10, 2019 by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on May 15, 2019)

First Amendment to Revolving Credit Note and Second Amendment to Revolving Credit Loan Agreement, dated as of October 17, 2018, by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on May 15, 2019)

Asset Purchase Agreement, dated November 1, 2018, by and among Cumberland Pharmaceuticals Inc., Theravance Biopharma Ireland Limited, and Theravance Biopharma US (Filed With SEC on November 16, 2018)

First Amendment to Revolving Credit Note and Second Amendment to Revolving Credit Loan Agreement, dated as of October 17, 2018, by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on November 14, 2018)

First Amendment to Revolving Credit Note and Second Amendment to Revolving Credit Loan Agreement, dated as of October 17, 2018, by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on October 19, 2018)

Amendment to Revolving Credit Loan Agreement, by and between Pinnacle Bank and Cumberland Pharmaceutical Inc., dated August 1 (Filed With SEC on August 14, 2018)

Revolving Credit Loan Agreement, dated July 31, 2017, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on November 8, 2017)

SECOND AMENDMENT TO REVOLVING CREDIT LOAN AGREEMENT (Filed With SEC on March 13, 2017)

FIRST AMENDMENT TO REVOLVING CREDIT LOAN AGREEMENT (Filed With SEC on November 3, 2016)

REVOLVING CREDIT LOAN AGREEMENT dated as of June 26, 2014 between CUMBERLAND PHARMACEUTICALS INC., as Borrower and SUNTRUST BANK the Lender Table of Contents (Filed With SEC on August 8, 2014)

WAIVER (Filed With SEC on March 11, 2014)

WAIVER AND SECOND AMENDMENT TO FIFTH AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on March 12, 2013)

FIRST AMENDMENT TO FIFTH AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on March 12, 2013)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. ASSET PURCHASE AND ROYALTY... (Filed With SEC on November 22, 2011)

THIRD AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on May 21, 2008)

EX-4.1 SPECIMEN COMMON STOCK CERTIFICATE (Filed With SEC on August 6, 2007)

Ex-10.16.3 Second Amendment to Second Amended and Restated Loan Agreement (Filed With SEC on July 23, 2007)

Ex-1.1 Form of Underwriting Agreement (Filed With SEC on July 23, 2007)

Category

Industry

Companies

Contracts

CUMBERLAND PHARMACEUTICALS INC Business Finance Contracts & Agreements